UK markets close in 2 hours 52 minutes

AstraZeneca PLC (AZN.L)

LSE - LSE Delayed price. Currency in GBp
Add to watchlist
8,637.00-73.00 (-0.84%)
As of 1:23PM BST. Market open.
Currency in GBp

Valuation measures

Market cap (intra-day) 5133.8B
Enterprise value 3128.55B
Trailing P/E 41.11
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)4.53
Price/book (mrq)722.88
Enterprise value/revenue 34.35
Enterprise value/EBITDA 719.37

Trading information

Stock price history

Beta (5Y monthly) 0.19
52-week change 3-1.16%
S&P500 52-week change 334.52%
52-week high 38,848.00
52-week low 36,499.80
50-day moving average 38,410.50
200-day moving average 38,012.14

Share statistics

Avg vol (3-month) 33.35M
Avg vol (10-day) 32.74M
Shares outstanding 51.55B
Implied shares outstanding 6N/A
Float 1.31B
% held by insiders 10.32%
% held by institutions 147.72%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 42.02
Forward annual dividend yield 42.32%
Trailing annual dividend rate 32.80
Trailing annual dividend yield 30.03%
5-year average dividend yield 43.51
Payout ratio 499.04%
Dividend date 3N/A
Ex-dividend date 412 Aug 2021
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2020
Most-recent quarter (mrq)30 Jun 2021

Profitability

Profit margin 12.77%
Operating margin (ttm)13.41%

Management effectiveness

Return on assets (ttm)3.70%
Return on equity (ttm)25.67%

Income statement

Revenue (ttm)29.53B
Revenue per share (ttm)22.51
Quarterly revenue growth (yoy)31.00%
Gross profit (ttm)21.37B
EBITDA 6.64B
Net income avi to common (ttm)3.77B
Diluted EPS (ttm)210.10
Quarterly earnings growth (yoy)-27.20%

Balance sheet

Total cash (mrq)15.63B
Total cash per share (mrq)11.91
Total debt (mrq)29.89B
Total debt/equity (mrq)190.47
Current ratio (mrq)1.23
Book value per share (mrq)11.95

Cash flow statement

Operating cash flow (ttm)6.45B
Levered free cash flow (ttm)5.87B